Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2016

View Archived Issues

Genentech initiates phase I trial of GDC-0134 in patients with ALS

Worldwide collaborations to control recent Zika virus outbreaks / News in Context

Researchers identify germline variants associated with melanoma prognosis

FDA approves Athenex's IND application for oradoxel

FDA accepts BLA submission for brodalumab in moderate to severe plaque psoriasis

Ixchelsis reports positive phase IIa results for IX-01 as treatment of premature ejaculation

Domainex and Cresset Discovery Services form alliance

Alkermes begins phase I clinical testing of ALKS-7119

FDA accepts for review cardiovascular outcomes data for Jardiance

Phase IIa study of GLPG-1205 in ulcerative colitis does not meet efficacy endpoints

Steba completes phase III trial of Tookad, submits MAA

Biomarkers linked to metastasis of endometrial and lung tumors

OncoMed unblinds phase II trial of tarextumab following DSMB analysis

Shire resubmits NDA for lifitegrast for dry eye disease

Results from part A of MoveDMD trial of CAT-1004 support progression to part B

WuXi Healthcare Ventures invests in Twist Bioscience and Syros Pharmaceuticals

Pharmaceutical industry calls for government collaboration to fight antibiotic resistance

Polish institutions report 5-HT/dopamine receptor modulators

Moberg Pharma issues a 5-year senior unsecured bond loan

Sunshine Lake Pharma discloses JAK3 inhibitors

Novartis reports soluble guanylate cyclase activators

Galapagos and Gilead Sciences file transparency notification

New animal model designed to reproduce ischemia in head and neck surgery

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Tissue-engineered cartilage shows promise for laryngotracheal reconstruction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...